RBC Capital Maintains Outperform on Verastem, Raises Price Target to $16

Benzinga · 01/07 15:23
RBC Capital analyst Gregory Renza maintains Verastem (NASDAQ:VSTM) with a Outperform and raises the price target from $13 to $16.